Sunshine Global Circuits
300739
Guangdong Brandmax Marketing
300805
Shengyi Electronics
688183
ZECHENG ELECTRONICS
837821
Jiangsu Jinling Sports Equipment
300651
CN Stock MarketDetailed Quotes
000702 Hunan Zhenghong Science And Technology Develop
- 7.72
- -0.59-7.10%
Market Closed Dec 17 15:00 CST
2.68BMarket Cap-24.51P/E (TTM)
8.36High7.70Low149.15KlotVolume8.25Open8.31Pre Close117.53MTurnover5.59%Turnover RatioLossP/E (Static)346.62MShares10.5552wk High6.54P/B2.06BFloat Cap2.9452wk Low9.14Limit Up266.63MShs Float22.79Historical High7.48Limit Down7.94%Amplitude2.35Historical Low--Dividend TTM7.88Avg Price83.52KlotAsk--Div YieldTTM100Lot Size60.05KlotBid
Hunan Zhenghong Science And Technology Develop Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -13.39%194.8M | 24.37%204.41M | 36.48%170.97M | 223.38%248.54M | 126.99%224.93M | 56.79%164.36M | 107.48%125.27M | -24.84%76.86M | -7.68%99.09M | -19.10%104.83M |
| Transactional financial assets | ---- | -20.95%1.55M | ---- | ---- | --1.5M | --1.96M | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | 43.40%52.01M | 131.23%50.25M | 408.49%41.96M | 34.59%21.19M | 317.79%36.27M | 4,068.54%21.73M | 183.19%8.25M | 317.76%15.74M | 43.56%8.68M | -90.43%521.29K |
| -Accounts receivable | 43.40%52.01M | 131.23%50.25M | 408.49%41.96M | 34.59%21.19M | 317.79%36.27M | 4,068.54%21.73M | 183.19%8.25M | 317.76%15.74M | 43.56%8.68M | -90.43%521.29K |
| Other receivables (including interest and dividends) | -77.02%1.65M | -74.55%1.68M | -77.45%1.73M | -73.22%1.55M | 20.65%7.18M | 23.50%6.61M | 46.35%7.66M | 24.74%5.8M | -40.74%5.95M | 31.73%5.35M |
| -Other receivable | ---- | -74.55%1.68M | ---- | ---- | ---- | 23.50%6.61M | ---- | 24.74%5.8M | ---- | 31.73%5.35M |
| Advance payment | -36.04%15.48M | 0.63%21.38M | 13.57%18.05M | -19.07%13.71M | 38.05%24.2M | 197.86%21.25M | 42.13%15.89M | 121.64%16.94M | -11.82%17.53M | -68.04%7.13M |
| Inventories | 27.44%138.56M | -36.76%82.34M | -51.24%83.16M | -68.76%68.76M | -47.36%108.73M | -38.18%130.2M | -24.26%170.56M | -3.38%220.1M | -13.10%206.54M | -39.47%210.6M |
| Other current assets | 76.26%3.18M | 171.66%1.05M | -50.33%626.69K | -45.22%414.07K | 255.96%1.8M | -66.30%385.24K | -44.55%1.26M | -79.29%755.93K | -79.23%506.7K | -56.02%1.14M |
| Total current assets | 0.26%405.68M | 4.67%362.65M | -3.77%316.49M | 5.35%354.17M | 19.60%404.62M | 5.13%346.49M | 7.07%328.89M | -3.88%336.19M | -13.63%338.3M | -36.83%329.58M |
| Non Current assets | ||||||||||
| Other equity investment | 7.82%29.52M | 2.03%24.69M | 0.97%26.04M | 2.43%24.18M | 12.98%27.38M | -2.53%24.2M | 3.41%25.79M | -18.62%23.61M | -19.93%24.24M | -28.31%24.83M |
| Other non-current financial assets | ---- | --195.71K | --532.71K | --995.39K | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | 74.97%114.35M | 74.48%116.65M | 73.75%118.98M | 72.96%121.25M | -8.59%65.35M | -8.26%66.86M | -7.79%68.48M | -7.34%70.1M | -1.57%71.49M | -1.46%72.88M |
| Long-term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -36.35%2.97M | -15.69%3.89M |
| Long term receivable account | --965.78K | --2.67M | --3.08M | --3.07M | ---- | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | -25.58%173.45M | ---- | ---- | ---- | -8.17%233.08M | ---- | -7.67%243.01M | ---- | -4.32%253.81M |
| Constru in process | ---- | --238.3K | ---- | ---- | ---- | ---- | ---- | -85.54%36K | ---- | -99.23%32K |
| Productive biological assets | -11.63%12.25M | -29.93%12.66M | -56.69%11.3M | -85.04%5.3M | -62.49%13.86M | -61.48%18.07M | -38.39%26.08M | -23.57%35.45M | -46.66%36.96M | -54.99%46.91M |
| Intangible assets | -71.25%7.11M | -72.33%6.98M | -69.55%7.82M | -68.67%8.21M | -5.81%24.75M | -0.97%25.24M | -0.75%25.69M | -3.03%26.19M | -4.38%26.28M | -8.29%25.49M |
| Usufruct assets | -69.36%13.09M | -72.35%14.78M | -71.61%16.29M | -72.14%17.29M | -45.77%42.74M | -42.69%53.43M | -36.94%57.37M | -41.07%62.05M | -21.92%78.8M | 9.52%93.23M |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.01M |
| Total non current assets | -13.78%346.6M | -16.29%352.33M | -17.56%364.08M | -20.95%363.99M | -17.73%401.99M | -19.38%420.88M | -15.22%441.65M | -16.48%460.45M | -15.02%488.6M | -12.95%522.07M |
| Total assets | -6.74%752.28M | -6.83%714.98M | -11.68%680.57M | -9.85%718.15M | -2.45%806.61M | -9.90%767.37M | -6.95%770.54M | -11.59%796.64M | -14.45%826.9M | -24.06%851.65M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 9.91%296.75M | -35.64%276.75M | -38.31%246.75M | -38.37%265.33M | -37.93%270M | -0.86%430M | 7.67%400M | 11.42%430.55M | 6.60%435M | 11.22%433.74M |
| Transactional financial liabilities | ---- | --2.97M | ---- | 16.81%1.75M | ---- | ---- | --411.44K | --1.5M | ---- | ---- |
| Notes payable and accounts payable | -9.49%57.84M | -46.70%36.84M | -40.84%37.38M | -60.65%37.14M | -31.19%63.9M | -21.49%69.11M | -25.11%63.19M | 16.05%94.39M | -16.03%92.87M | -0.27%88.04M |
| -Accounts payable | -9.49%57.84M | -46.70%36.84M | -40.84%37.38M | -60.65%37.14M | -31.19%63.9M | -21.49%69.11M | -25.11%63.19M | 16.05%94.39M | 6.02%92.87M | 3.24%88.04M |
| Contract liabilities | 116.86%31.18M | 62.80%21.55M | 20.38%15.4M | 74.24%9.58M | 12.97%14.38M | -33.73%13.24M | -52.63%12.79M | -46.71%5.5M | 25.81%12.73M | -13.79%19.98M |
| Advance receipts | 3.29%557.28K | 55.28%860.95K | 42.58%757.45K | 156.08%1.25M | 35.59%539.53K | 139.77%554.46K | 39.37%531.24K | 2.46%488.21K | 20.31%397.91K | -3.48%231.24K |
| Salaries payable | 8.70%9.61M | -8.87%9.81M | -30.83%9.21M | 51.99%12.57M | -3.80%8.84M | 0.85%10.77M | 16.25%13.32M | -25.33%8.27M | -26.02%9.19M | -17.64%10.68M |
| Taxs payable | -39.83%2.35M | -39.55%1.83M | -35.17%1.6M | -41.96%1.91M | 1.80%3.91M | -17.87%3.04M | -16.75%2.46M | -38.70%3.29M | 78.38%3.84M | 63.10%3.7M |
| Other payable (including interest and dividends) | -38.89%17.66M | -87.25%18.08M | -86.13%20.1M | -58.52%29.53M | 4.56%28.9M | 431.89%141.8M | 425.82%144.94M | 169.95%71.18M | -35.24%27.64M | -37.77%26.66M |
| -Other payable | ---- | -87.25%18.08M | ---- | ---- | ---- | 431.89%141.8M | ---- | 169.95%71.18M | ---- | -37.77%26.66M |
| Non current liabilities due within one year | -73.66%3.15M | -50.04%7.88M | -51.03%8.3M | -61.44%7.59M | --11.95M | --15.77M | --16.94M | --19.68M | ---- | ---- |
| Other current liabilities | ---- | ---- | ---- | --157.6K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current liabilities | 4.14%419.1M | -44.97%376.57M | -48.05%340.07M | -42.22%366.81M | -30.82%402.42M | 17.37%684.28M | 24.62%654.59M | 21.77%634.85M | -0.80%581.67M | 4.16%583.03M |
| Current liabilities | ||||||||||
| Long term deferred income | -11.45%8.42M | -11.13%8.7M | -10.84%8.97M | -10.55%9.24M | -10.28%9.51M | -10.76%9.79M | -10.54%10.06M | -9.54%10.33M | -6.09%10.6M | -5.16%10.96M |
| Lease liabilities | -71.76%7.01M | -72.15%8.16M | -72.36%8.16M | -67.43%11.14M | -64.04%24.81M | -63.64%29.28M | -62.69%29.51M | -61.97%34.21M | -13.35%68.99M | 13.56%80.54M |
| Total non current liabilities | -55.05%15.43M | -56.87%16.85M | -56.73%17.12M | -54.23%20.38M | -56.88%34.32M | -57.31%39.07M | -56.20%39.57M | -56.07%44.54M | -12.45%79.59M | 10.94%91.5M |
| Total liabilities | -0.51%434.53M | -45.61%393.42M | -48.54%357.19M | -43.01%387.19M | -33.95%436.74M | 7.24%723.35M | 12.76%694.16M | 9.10%679.38M | -2.36%661.26M | 5.03%674.53M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%346.62M | 30.00%346.62M | 30.00%346.62M | 30.00%346.62M | 30.00%346.62M | 0.00%266.63M | 0.00%266.63M | 0.00%266.63M | 0.00%266.63M | 0.00%266.63M |
| Capital reserve funds | 0.00%436.58M | 136.37%436.58M | 136.37%436.58M | 136.37%436.58M | 136.37%436.58M | 0.00%184.7M | 0.00%184.7M | -0.61%184.7M | 1.81%184.7M | 1.61%184.7M |
| Surplus reserve funds | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 1.32%29.99M | 1.32%29.99M |
| Retained profit | -31.20%-430.97M | -29.33%-419.95M | -36.96%-417.3M | -48.34%-408.73M | -36.50%-328.49M | -39.71%-324.71M | -49.16%-304.7M | -72.70%-275.53M | -54.54%-240.65M | -694.81%-232.42M |
| Other composite income | 3.42%26.94M | -3.31%22.11M | -4.08%23.46M | 3.71%23.1M | 13.73%26.05M | -2.68%22.87M | 3.61%24.46M | -19.52%22.27M | -20.84%22.9M | -29.44%23.5M |
| Shareholders equity without minority interests | -19.89%409.16M | 131.42%415.35M | 108.55%419.36M | 87.47%427.56M | 93.78%510.76M | -34.11%179.48M | -33.12%201.09M | -34.95%228.07M | -24.88%263.57M | -43.49%272.4M |
| Minority interests | 35.12%-91.41M | 30.76%-93.79M | 23.04%-95.97M | 12.83%-96.6M | -43.87%-140.89M | -42.18%-135.45M | -41.44%-124.71M | -53.42%-110.82M | -59.16%-97.93M | -3,274.53%-95.27M |
| Total shareholder equity | -14.09%317.75M | 630.42%321.56M | 323.39%323.38M | 182.26%330.96M | 123.29%369.86M | -75.14%44.02M | -64.06%76.38M | -57.88%117.25M | -42.75%165.65M | -63.04%177.12M |
| Total liabilityies and equity | -6.74%752.28M | -6.83%714.98M | -11.68%680.57M | -9.85%718.15M | -2.45%806.61M | -9.90%767.37M | -6.95%770.54M | -11.59%796.64M | -14.45%826.9M | -24.06%851.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
